APA
Le Bourgeois A., Labopin M., Blaise D., Ceballos P., Vigouroux S., Peffault de Latour R., Marçais A., Bulabois C. E., Bay J. O., Chantepie S., Deconinck E., Daguindau E., Contentin N., Yakoub-Agha I., Cornillon J., Mercier M., Turlure P., Charbonnier A., Rorhlich P. S., N'Guyen S., Maillard N., Marchand T., Mohty M. & Chevallier P. (20180523). Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. : Annals of oncology : official journal of the European Society for Medical Oncology.
Chicago
Le Bourgeois A, Labopin M, Blaise D, Ceballos P, Vigouroux S, Peffault de Latour R, Marçais A, Bulabois C E, Bay J O, Chantepie S, Deconinck E, Daguindau E, Contentin N, Yakoub-Agha I, Cornillon J, Mercier M, Turlure P, Charbonnier A, Rorhlich P S, N'Guyen S, Maillard N, Marchand T, Mohty M and Chevallier P. 20180523. Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. : Annals of oncology : official journal of the European Society for Medical Oncology.
Harvard
Le Bourgeois A., Labopin M., Blaise D., Ceballos P., Vigouroux S., Peffault de Latour R., Marçais A., Bulabois C. E., Bay J. O., Chantepie S., Deconinck E., Daguindau E., Contentin N., Yakoub-Agha I., Cornillon J., Mercier M., Turlure P., Charbonnier A., Rorhlich P. S., N'Guyen S., Maillard N., Marchand T., Mohty M. and Chevallier P. (20180523). Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. : Annals of oncology : official journal of the European Society for Medical Oncology.
MLA
Le Bourgeois A, Labopin M, Blaise D, Ceballos P, Vigouroux S, Peffault de Latour R, Marçais A, Bulabois C E, Bay J O, Chantepie S, Deconinck E, Daguindau E, Contentin N, Yakoub-Agha I, Cornillon J, Mercier M, Turlure P, Charbonnier A, Rorhlich P S, N'Guyen S, Maillard N, Marchand T, Mohty M and Chevallier P. Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. : Annals of oncology : official journal of the European Society for Medical Oncology. 20180523.